Bio-Thera Ventures Outside China With European Bevacizumab Filing
Files BAT1706 Biosimilar Of Avastin With EMA; FDA Filing Coming Soon
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
